On November 13, 2026 Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, reported that management will present at the following investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

UBS Global Biopharma London Conference
November 17, 2026
1:20 p.m. GMT/ 8:20 a.m. ET / 5:20 a.m. PT

Jefferies Global Healthcare Conference
November 18, 2026
2:30 p.m. GMT/ 9:30 a.m. ET / 6:30 a.m. PT

Live audio webcasts will be available in the Investors section of Kura’s website at View Source, with archived replays available following the events.

(Press release, Kura Oncology, NOV 13, 2026, View Source [SID1234674764])